NovaBay Pharmaceuticals, Inc. — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2021-12-01

Reporting Person: Kunin Audrey (Chief Product Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-01	Common Stock	P	14848	$0.49	Acquired	135981	Indirect

Footnotes

F1: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.